Skip to content

Australian Cancer Research Foundation

Professional services

UnclaimedRequest correction

An Australian not-for-profit foundation that funds cancer research infrastructure, equipment and technology.

Last updated August 24, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

The Australian Cancer Research Foundation (ACRF) is an Australian not-for-profit organisation established to accelerate research into the prevention, diagnosis and treatment of cancer. Rather than operating as a conventional consumer brand or conducting research primarily under its own name, the Foundation acts as a grant-making and philanthropic platform. It supports cancer scientists and clinicians by financing research equipment, technology and infrastructure used by universities, hospitals and medical research institutes across Australia. ACRF was established in 1984 by businessman and philanthropist Sir Peter Abeles AC. Lady Sonia McMahon was also an early Board member and remained associated with the Foundation until her death in 2010. The organisation’s institutional model is based on independent assessment of research proposals and allocation of substantial grants to projects judged likely to produce significant benefits for cancer prevention, diagnosis or treatment. The Foundation funds research across all cancer types. Its grants are intended to strengthen the practical capabilities of research teams, including through the acquisition of advanced scientific equipment, development of research facilities and deployment of technologies that enable investigators to undertake high-quality studies. Grant decisions consider scientific excellence, the coherence of the proposed research programme, the qualifications of the team and the quality of governance surrounding the project. Individual awards are described as ranging from approximately $1.5 million to $10 million. Governance is provided by a Board of Trustees made up of prominent Australians. The Board is supported by a Medical Research Advisory Committee, or MRAC, whose membership includes Australian and international cancer specialists. The committee evaluates applications, shortlists candidates for panel interviews and advises the trustees on which proposals are most likely to have a high impact. MRAC membership is authorised by the National Health and Medical Research Council. The Foundation’s stated current co-chairs are Michelle Haber AM and Professor Ricky Johnstone, while Tim Cooper AM is identified as chair of the Board of Trustees. ACRF is privately funded and receives no government funding. Its public-facing role is therefore closely tied to donor support and philanthropic accountability. The Foundation states that it makes its financial statements publicly available. According to the referenced organisational information, it has awarded more than A$209 million through 93 grants to 44 Australian research institutes, universities and hospitals. These figures describe cumulative grant activity rather than commercial sales or operating revenue. The Foundation’s positioning is that of a national, independent funder of enabling cancer research infrastructure. Its work spans the research pipeline rather than a single disease subtype or therapeutic product, and its beneficiaries are research institutions and clinical-scientific teams rather than direct retail consumers. Its impact is consequently measured through the capabilities and discoveries enabled by funded infrastructure and technology.

History

The Australian Cancer Research Foundation was created in 1984 by Sir Peter Abeles AC, a businessman and philanthropist who sought to support cancer research in Australia. Lady Sonia McMahon was among the Foundation’s founding Board members and continued in that role until her death in 2010. From its establishment, ACRF developed as a philanthropic grant-maker rather than as a research laboratory, hospital operator or commercial healthcare company. Its central purpose is to provide Australian cancer researchers with the physical and technological capacity required to conduct advanced work. The Foundation funds infrastructure, equipment and technology supporting research into all forms of cancer, with applications coming from research institutes, universities and hospitals. This approach allows grants to support broad programmes and shared scientific capabilities, rather than limiting funding to one cancer type or one stage of the research process. ACRF is governed by a Board of Trustees composed of prominent and influential Australians. The trustees are assisted by a Medical Research Advisory Committee made up of Australian and international experts in cancer research. The committee assesses grant applications, identifies applicants for panel interviews and advises the Board on proposals with the greatest likely effect on cancer prevention, diagnosis and treatment. Its membership is authorised by the National Health and Medical Research Council, adding an external scientific-governance dimension to the selection process. The Foundation describes its awards as generally ranging from $1.5 million to $10 million. Selection is based on scientific quality, the cohesion of the proposed research programme, the capability of the research team and the strength of institutional governance. Through this model, ACRF has supported projects at 44 Australian research institutes, universities and hospitals. The organisation reports cumulative awards exceeding $209 million, delivered through 93 grants. Unlike a government research agency, ACRF is privately funded and receives no government funding. Its operations and grant-making are therefore dependent on private philanthropy and donor confidence. The Foundation states that financial statements are publicly available, reflecting an emphasis on accountability for funds raised and distributed. In its current structure, Tim Cooper AM is identified as chair of the Board of Trustees. Michelle Haber AM and Professor Ricky Johnstone are identified as co-chairs of the Medical Research Advisory Committee. The Foundation continues to present itself as a national funding organisation whose contribution lies in enabling scientists and clinicians to undertake cancer research with modern facilities, equipment and technology.

  • 2010

    Death of founding Board member Sonia McMahon

    [1]

    Lady Sonia McMahon, who had served as a founding Board member, died in 2010.

  • 1984

    Foundation established

    [1]

    Sir Peter Abeles AC established the Australian Cancer Research Foundation as a philanthropic organisation supporting cancer research in Australia.

Products and positioning

An independent Australian philanthropic funder that strengthens cancer research capabilities across universities, hospitals and medical research institutes.

  • Cancer research funding · 1984

    ACRF research grants

    Large philanthropic grants awarded to Australian universities, hospitals and medical research institutes. Awards support research infrastructure, scientific equipment and technology for programmes addressing cancer prevention, diagnosis and treatment. The Foundation states that grants typically range from $1.5 million to $10 million and are assessed for scientific excellence, programme coherence, team capability and governance.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/australian-cancer-research-foundation · Editorial policy · How profiles are compiled